{
  "query": "months retinal acuity adverse",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT06779773",
          "briefTitle": "A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Geographic Atrophy", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04218565",
          "briefTitle": "Golimumab for the Treatment of Refractory Behcet's Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Behcet Syndrome", "Uveitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06310837",
          "briefTitle": "Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Uveitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04925687",
          "briefTitle": "Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00606138",
          "briefTitle": "Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Proliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03108352",
          "briefTitle": "Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Branch Retinal Vein Occlusion", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 255,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02671539",
          "briefTitle": "THOR - Tübingen Choroideremia Gene Therapy Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Choroideremia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06033703",
          "briefTitle": "Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rhegmatogenous Retinal Detachment", "Proliferative Vitreoretinopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04855045",
          "briefTitle": "An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leber Congenital Amaurosis 10", "Blindness", "Leber Congenital Amaurosis", "Vision Disorders", "Sensation Disorders", "Neurologic Manifestations", "Eye Diseases", "Eye Disorders Congenital", "Retinal Disease", "Retinal Degeneration", "Retinal Dystrophies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "7 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06343961",
          "briefTitle": "Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Vascular Retinopathy of Left Eye (Disorder)", "Vascular Retinopathy of Right Eye (Disorder)", "Diabetic Retinopathy", "Retinal Vein Occlusion", "Retinal Vasculitis", "Vitreous Hemorrhage"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05562284",
          "briefTitle": "Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Central Retinal Artery Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01442064",
          "briefTitle": "An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2010-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Edema", "Retinal Vein Occlusion"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 608,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01780935",
          "briefTitle": "Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-07-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 671,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03316560",
          "briefTitle": "Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "X-Linked Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "6 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01342926",
          "briefTitle": "Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06-01"
          },
          "completionDateStruct": {
            "date": "2016-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atrophy, Geographic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 191,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03499223",
          "briefTitle": "A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-07-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Diabetic Retinopathy", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00679445",
          "briefTitle": "A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12"
          },
          "completionDateStruct": {
            "date": "2011-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02934841",
          "briefTitle": "Conbercept in Choroidal Neovascularization Secondary to Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11"
          },
          "completionDateStruct": {
            "date": "2018-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Choroidal Neovascularization", "Uveitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02620618",
          "briefTitle": "Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Behçet's Disease", "Uveitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05712720",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06460844",
          "briefTitle": "Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa", "Choroideremia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03197493",
          "briefTitle": "Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macula; Degeneration", "Retina"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03862313",
          "briefTitle": "Repetitive Transorbital Alternating Current Stimulation in Acute Autoimmune Optic Neuritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Autoimmune Inflammatory Optic Neuritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00135837",
          "briefTitle": "Photodynamic Therapy in Occult-Only Lesions (POOL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-06"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 202
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01257815",
          "briefTitle": "Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01"
          },
          "completionDateStruct": {
            "date": "2013-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Retinopathy", "Macular Oedema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 111,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04545736",
          "briefTitle": "Oral Metformin for Treatment of ABCA4 Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ABCA4 Retinopathy", "Stargardt Disease", "Retinal Dystrophy", "Retinal Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06699914",
          "briefTitle": "A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 438,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06118398",
          "briefTitle": "Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-05-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neuromyelitis Optica", "Efgartigimod"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02215330",
          "briefTitle": "A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2017-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Central Serous Chorioretinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00826371",
          "briefTitle": "Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Age Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02661711",
          "briefTitle": "Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Oedema", "Retinitis Pigmentosa"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05820152",
          "briefTitle": "Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leber Hereditary Optic Neuropathy (LHON)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06682962",
          "briefTitle": "Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Glaucoma", "Primary Open Angle Glaucoma", "Pseudoexfoliation Glaucoma", "Pigment Dispersion Glaucoma", "Normal Tension Glaucoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01847365",
          "briefTitle": "TES for the Treatment of RP"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2015-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01506895",
          "briefTitle": "A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2013-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinopathy, Diabetic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01015495",
          "briefTitle": "Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12"
          },
          "completionDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Angioid Streaks"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04656561",
          "briefTitle": "A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Geographic Atrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 270,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05086588",
          "briefTitle": "Safety and Efficacy Evaluation of Two Different Brilliant Blue G Dyes as Staining Agent in Vitreo Retinal Surgery."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Holes", "Epiretinal Membrane"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02142296",
          "briefTitle": "Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03759860",
          "briefTitle": "Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02911311",
          "briefTitle": "Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Proliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 226,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00424710",
          "briefTitle": "Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-01"
          },
          "completionDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Polypoidal Choroidal Vasculopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01136252",
          "briefTitle": "Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05"
          },
          "completionDateStruct": {
            "date": "2011-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Age-Related Macular Degeneration", "Choroidal Neovascularization"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02658435",
          "briefTitle": "Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria, Vivax"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 486,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06798285",
          "briefTitle": "Comparision of Retinal Function and Macular Structure After 27G Pars Plana Vitrectomy With Minimal Illuminiation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epiretinal Membrane"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04041232",
          "briefTitle": "PBA Use for Treatment of ATF6-/- Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ACHROMATOPSIA 7", "Achromatopsia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02320812",
          "briefTitle": "Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06"
          },
          "completionDateStruct": {
            "date": "2017-07-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa (RP)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03383731",
          "briefTitle": "A Study of a New Surgical Treatment of Macular Hole Retinal Detachment in High Myopia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Holes", "Retinal Detachment", "High Myopia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03802630",
          "briefTitle": "Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Branch Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03006081",
          "briefTitle": "The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03717909",
          "briefTitle": "Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Wolfram Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06845163",
          "briefTitle": "Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Macular Edema", "Center-involved Diabetic Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04850118",
          "briefTitle": "A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "X-Linked Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "12 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04684394",
          "briefTitle": "A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Neovascular Age-related Macular Degeneration", "Retinal Disease", "Retinal Degeneration", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06093880",
          "briefTitle": "Observational, Prospective Clinical Investigation on Mini 4 Ready Intraocular Lens"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cataract"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01580020",
          "briefTitle": "Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 175,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03423823",
          "briefTitle": "Ziv-aflibercept Efficacy in Better Regulating AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Wet Macular Degeneration", "Wet Age-related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01025232",
          "briefTitle": "A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12"
          },
          "completionDateStruct": {
            "date": "2013-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Age Related Macular Degeneration", "Choroidal Neovascular Membrane", "Subfoveal Neovascular Age-Related Macular Degeneration", "Macular Degeneration", "Wet Age-Related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00711490",
          "briefTitle": "Sirolimus to Treat Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04504123",
          "briefTitle": "MMP-9 Inhibition for Recalcitrant Wet AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Exudative Macular Degeneration", "Wet Age-related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00090519",
          "briefTitle": "Reduction in the Occurrence of Center-Involved Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-02"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 731,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00889421",
          "briefTitle": "Apremilast in the Treatment of Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11"
          },
          "completionDateStruct": {
            "date": "2011-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Uveitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01988662",
          "briefTitle": "UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovacular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 205,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07160179",
          "briefTitle": "Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Geographic Atrophy", "Age-Related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06912633",
          "briefTitle": "Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00363168",
          "briefTitle": "Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-08"
          },
          "completionDateStruct": {
            "date": "2009-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Choroidal Neovascularization"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03386474",
          "briefTitle": "Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04524910",
          "briefTitle": "A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myopic Choroidal Neovascularization"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02719002",
          "briefTitle": "Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Toxicity, Drug", "Maculopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05839041",
          "briefTitle": "A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Geographic Atrophy of the Macula", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05610488",
          "briefTitle": "Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00918554",
          "briefTitle": "Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2010-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sarcoid-associated Uveitis", "Ocular Sarcoidosis", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02294656",
          "briefTitle": "Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "CYSTOID MACULAR EDEMA"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06398080",
          "briefTitle": "An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neovascular Age-related Macular Degeneration (nAMD)", "Wet Age-related Macular Degeneration (AMD)", "Diabetic Macular Edema (DME)", "Visual Impairment"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03439345",
          "briefTitle": "Lowering Events in Non-proliferative Retinopathy in Scotland"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02146144",
          "briefTitle": "Prospective, Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery (Peeling)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Epimacular Membrane"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 213,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02554214",
          "briefTitle": "Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Glaucoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06132035",
          "briefTitle": "Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Wet Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01884597",
          "briefTitle": "Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["PCV", "Polypoidal Choroidal Vasculopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "25 Years",
          "maximumAge": "95 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00027287",
          "briefTitle": "Laser and Medical Treatment of Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-11"
          },
          "completionDateStruct": {
            "date": "2002-12"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01857544",
          "briefTitle": "Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04919499",
          "briefTitle": "A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03861234",
          "briefTitle": "A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05293626",
          "briefTitle": "Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leber Hereditary Optic Neuropathy (LHON)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03999801",
          "briefTitle": "Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neovascular Age-related Macular Degeneration", "Wet Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 865,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04744467",
          "briefTitle": "PMCF Study on Monofocal Toric IOL (PODEYE TORIC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cataract", "Lens Opacities", "Astigmatism"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02110225",
          "briefTitle": "A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04287348",
          "briefTitle": "Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03751501",
          "briefTitle": "Targeted Laser in Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Edema", "Diabetic Retinopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 270,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02403128",
          "briefTitle": "Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Edema", "Retinal Artery Macroaneurysm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02834663",
          "briefTitle": "Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Nonproliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03465111",
          "briefTitle": "A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Scleritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01436864",
          "briefTitle": "A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03823287",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 671,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01934556",
          "briefTitle": "A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11"
          },
          "completionDateStruct": {
            "date": "2018-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06068829",
          "briefTitle": "Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neuromyelitis Optica Spectrum Disorders"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01148511",
          "briefTitle": "Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus \"Treat and Extend\" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00403442",
          "briefTitle": "Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01628354",
          "briefTitle": "Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-02"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Choroidal Neovascularization", "Retinal Pigment Epithelial Detachment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03085784",
          "briefTitle": "Intravitreal Aflibercept Injection for Radiation Retinopathy Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Radiation Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT06184360",
          "briefTitle": "Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular (Wet) Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2079,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04424290",
          "briefTitle": "HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00676559",
          "briefTitle": "Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03725566",
          "briefTitle": "JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04072978",
          "briefTitle": "Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Corneal Endothelial Cell Loss", "Secondary Intraocular Lens"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03556085",
          "briefTitle": "Venous Sinus Stenting With the River Stent in IIH"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Intracranial Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00726466",
          "briefTitle": "Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-03"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Age Related Macular Degeneration", "AMD", "CNV"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04749667",
          "briefTitle": "Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Progressive Multiple Sclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01336621",
          "briefTitle": "Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00280826",
          "briefTitle": "Efalizumab to Treat Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-01"
          },
          "completionDateStruct": {
            "date": "2009-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Uveitis", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01226628",
          "briefTitle": "A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02055911",
          "briefTitle": "Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03"
          },
          "completionDateStruct": {
            "date": "2015-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02659098",
          "briefTitle": "A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Visual Acuity", "Geographic Atrophy", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00470977",
          "briefTitle": "Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-05"
          },
          "completionDateStruct": {
            "date": "2010-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Coats' Disease", "Idiopathic Retinal Telangiectasia", "Retinal Angiomatous Proliferation", "Polypoidal Choroidal Vasculopathy", "Pseudoxanthoma Elasticum", "Pathological Myopia", "Multi-focal Choroiditis", "Rubeosis Iridis", "Von Hippel Lindau Disease", "BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02194634",
          "briefTitle": "Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07"
          },
          "completionDateStruct": {
            "date": "2017-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 248,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02386839",
          "briefTitle": "Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinopathy of Prematurity (ROP)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Weeks",
          "maximumAge": "108 Weeks"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03668054",
          "briefTitle": "Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01377597",
          "briefTitle": "Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01846273",
          "briefTitle": "Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Age-related Macular Degeneration", "Polypoidal Choroidal Vasculopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 321,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01217762",
          "briefTitle": "Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Age-Related Macular Degeneration", "Wet Age-Related Macular Degeneration", "Macular Degeneration", "Eye Diseases", "Retinal Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04588948",
          "briefTitle": "A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05082415",
          "briefTitle": "Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Macular Degeneration (AMD)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 9456,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05170048",
          "briefTitle": "Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03845582",
          "briefTitle": "Phase 2/3 Study of ALK-001 in Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Geographic Atrophy", "Age Related Macular Degeneration", "AMD", "Atrophy, Geographic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04735393",
          "briefTitle": "A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dry Eye Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 757,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05871840",
          "briefTitle": "Effectiveness and Safety of Repeated Low-Level Red-Light Therapy on Myopia Control Among Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myopia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "7 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05756959",
          "briefTitle": "Myopia Control Combined PBM With Myopic Defocus Lens in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myopia, Progressive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 304,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01635803",
          "briefTitle": "Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 296,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01189019",
          "briefTitle": "HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Wet Macular Degeneration", "Macular Degeneration", "Retinal Pigment Epithelial Detachment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06425419",
          "briefTitle": "The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Proliferative Vitreoretinopathy", "Proliferative Vitreo-Retinopathy", "Rhegmatogenous Retinal Detachment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03364153",
          "briefTitle": "Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Stargardt's Macular Dystrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 121,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06224751",
          "briefTitle": "Developing Better Computerised Vision Tests (CVTV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Visual Impairment", "Amblyopia", "Macular Degeneration", "Ophthalmic Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 550,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06915948",
          "briefTitle": "Postoperative Same Day Closure of Giant Macular Hole With Silicone Oil"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Holes", "Vitrectomy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05338450",
          "briefTitle": "Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Internuclear Ophthalmoplegia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01579760",
          "briefTitle": "Intravitreal Aflibercept Injection for Radiation Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-11"
          },
          "completionDateStruct": {
            "date": "2019-03-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Radiation Retinopathy", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03810313",
          "briefTitle": "Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Central Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 493,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06431113",
          "briefTitle": "Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Glaucoma", "Neuroprotection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00976235",
          "briefTitle": "A Long-Term Monitoring Study of the IMT-002 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-06"
          },
          "completionDateStruct": {
            "date": "2011-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 129,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00384449",
          "briefTitle": "Lucentis (Ranibizumab) for Eales' Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10"
          },
          "completionDateStruct": {
            "date": "2009-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eales' Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06583798",
          "briefTitle": "Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinal Detachment", "Proliferative Vitreo-Retinopathy", "Proliferative Diabetic Retinopathy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05015335",
          "briefTitle": "The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular Leakage"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Uveitis, Anterior", "Adalimumab"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06536062",
          "briefTitle": "Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Dry Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03249740",
          "briefTitle": "A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01994291",
          "briefTitle": "A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11"
          },
          "completionDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Edema, Diabetic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 199,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04698850",
          "briefTitle": "Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04619303",
          "briefTitle": "Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Macular Edema", "Diabetic Retinopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02448446",
          "briefTitle": "The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2018-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Macular Edema", "Hard Lipid Exudates"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01453920",
          "briefTitle": "Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-11"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06627179",
          "briefTitle": "Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa (RP)", "Usher Syndrome Type 2", "Deaf Blind", "Retinal Disease", "Eye Diseases, Hereditary", "Eye Disorders Congenital", "Vision Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "8 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03197194",
          "briefTitle": "A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Central Retinal Artery Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02931175",
          "briefTitle": "ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Uveitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00379795",
          "briefTitle": "An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-04"
          },
          "completionDateStruct": {
            "date": "2008-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Choroidal Neovascularization, Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 853,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04703712",
          "briefTitle": "Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glaucoma, Angle-Closure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 316,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01280929",
          "briefTitle": "Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "High Risk Proliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01581151",
          "briefTitle": "Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02543229",
          "briefTitle": "Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07"
          },
          "completionDateStruct": {
            "date": "2017-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Eye Diseases", "Macular Degeneration", "Retinal Diseases", "Retinal Degeneration", "Neovascularization, Pathologic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05038072",
          "briefTitle": "The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Edema", "Retinal Vein Occlusion"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04778501",
          "briefTitle": "PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cataract", "Lens Opacities", "Astigmatism"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05203939",
          "briefTitle": "Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa", "Leber Congenital Amaurosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02181400",
          "briefTitle": "Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Oedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06817265",
          "briefTitle": "Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Proliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01279954",
          "briefTitle": "Abatacept in the Treatment of Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Uveitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05990829",
          "briefTitle": "Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Macular Edema", "Pars Plana Vitrectomy", "Dexamethasone Intravitreal Implant", "Intraoperative Optical Coherence Tomography"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05349006",
          "briefTitle": "Azathioprine in MOGAD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Central Nervous System Inflammation", "MOG-IgG Associated Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00363714",
          "briefTitle": "A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11"
          },
          "completionDateStruct": {
            "date": "2007-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Age-Related Macular Degeneration", "Choroidal Neovascularization"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02060604",
          "briefTitle": "Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02700984",
          "briefTitle": "A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Open Angle Glaucoma (POAG)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 282,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02140164",
          "briefTitle": "Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2016-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03144999",
          "briefTitle": "Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dry Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05085964",
          "briefTitle": "An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa", "Usher Syndrome Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03845049",
          "briefTitle": "Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Telangiectasia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02121353",
          "briefTitle": "Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11"
          },
          "completionDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age Related Macular Degeneration (AMD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02390531",
          "briefTitle": "Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinopathy of Prematurity"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "6 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05176717",
          "briefTitle": "Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa", "Usher Syndrome Type 2", "Deaf Blind", "Retinal Disease", "Eye Diseases", "Eye Diseases, Hereditary", "Eye Disorders Congenital", "Vision Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02599064",
          "briefTitle": "Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11"
          },
          "completionDateStruct": {
            "date": "2018-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Age-related Macular Degeneration", "Subfoveal Choroidal Neovascularization", "Subretinal Scarring", "Subretinal Fibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05537220",
          "briefTitle": "Oral N-acetylcysteine for Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 483,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06817343",
          "briefTitle": "A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neovascular Age-Related Macular Degeneration (nAMD)", "Neovascular (Wet) Age-related Macular Degeneration (AMD)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05158296",
          "briefTitle": "Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa", "Usher Syndrome Type 2", "Deaf Blind", "Retinal Disease", "Eye Diseases", "Eye Diseases, Hereditary", "Eye Disorders Congenital", "Vision Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04482543",
          "briefTitle": "Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Proliferative Vitreoretinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01845844",
          "briefTitle": "Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04604899",
          "briefTitle": "Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02432547",
          "briefTitle": "Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04527107",
          "briefTitle": "A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Diabetic Retinopathy", "Diabetic Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 135,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03981549",
          "briefTitle": "Treatment of Central Retinal Vein Occlusion Using Stem Cells Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Central Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04116398",
          "briefTitle": "Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02034006",
          "briefTitle": "A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Choroidal Neovascularization Secondary to Pathologic Myopia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01552408",
          "briefTitle": "Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-05-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03362190",
          "briefTitle": "ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00685399",
          "briefTitle": "Safety and Efficacy of AIN457 in Noninfectious Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-infectious Uveitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00826618",
          "briefTitle": "Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Uveitic Cystoid Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06787482",
          "briefTitle": "Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinitis Pigmentosa (RP)", "Age Related Macular Degeneration", "Diabetic Retinopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04668703",
          "briefTitle": "Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Macular Edema", "Diabetic Retinopathy", "Cataract Diabetic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01157715",
          "briefTitle": "A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 122,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01565148",
          "briefTitle": "A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02553135",
          "briefTitle": "Choroideremia Gene Therapy Clinical Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Choroideremia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02503332",
          "briefTitle": "Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Geographic Atrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 246,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02425501",
          "briefTitle": "Special Drug Use Investigation of EYLEA for Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-08-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Edema"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 646,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05217680",
          "briefTitle": "Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 442,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01635790",
          "briefTitle": "Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 246,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02161575",
          "briefTitle": "Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT00055042",
          "briefTitle": "Laser and Antioxidant Treatment of Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-02"
          },
          "completionDateStruct": {
            "date": "2004-01"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Edema", "Diabetes Mellitus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02537054",
          "briefTitle": "Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09"
          },
          "completionDateStruct": {
            "date": "2018-07-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pseudoxanthoma Elasticum"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01577381",
          "briefTitle": "Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2013-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-Related Maculopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03023059",
          "briefTitle": "Dose Ranging Study of Carbidopa-levodopa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05893654",
          "briefTitle": "Melphalan Chemoreduction for Ocular Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Uveal Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01726075",
          "briefTitle": "Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02"
          },
          "completionDateStruct": {
            "date": "2015-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05706896",
          "briefTitle": "Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Dry Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06908824",
          "briefTitle": "No Endotamponade for Macular Hole Repair: the NEMAR Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Hole", "Macular Hole Surgery"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00331864",
          "briefTitle": "SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-04"
          },
          "completionDateStruct": {
            "date": "2008-04"
          }
        },
        "conditionsModule": {
          "conditions": ["Age Related Macular Degeneration", "Choroidal Neovascularization"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 531,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03073733",
          "briefTitle": "Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 84,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03071068",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Retinopathy", "Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00498355",
          "briefTitle": "Lucentis for Inflammatory Macular Edema Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-07"
          },
          "completionDateStruct": {
            "date": "2009-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Uveitis", "Cytoid Macular Edema"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02216123",
          "briefTitle": "Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria, Vivax"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 251,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01675947",
          "briefTitle": "Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Geographic Atrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07290244",
          "briefTitle": "Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2032-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Open Angle Glaucoma (OAG)", "NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04940572",
          "briefTitle": "Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Wolfram Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05520177",
          "briefTitle": "A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Branch Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 351,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00310375",
          "briefTitle": "Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 181,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07236645",
          "briefTitle": "Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-proliferative Diabetic Retinopathy (NPDR)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02309281",
          "briefTitle": "Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06275620",
          "briefTitle": "A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "X-Linked Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02665689",
          "briefTitle": "Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Visual Acuity Reduced Transiently", "Macular Edema, Cystoid"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01578720",
          "briefTitle": "Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Choroidal Neovascularization", "Presumed Ocular Histoplasmosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00310388",
          "briefTitle": "Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 376,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02402660",
          "briefTitle": "Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stargardt Disease", "Stargardt Macular Degeneration", "Stargardt Macular Dystrophy", "Autosomal Recessive Stargardt Disease 1 (ABCA4-related)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "8 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03865160",
          "briefTitle": "Low-dose Atropine for Myopia Control in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myopia, Progressive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "8 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01746875",
          "briefTitle": "A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Degeneration", "Retinal Detachment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01589718",
          "briefTitle": "A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04"
          },
          "completionDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Proliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02689518",
          "briefTitle": "EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Degeneration", "Wet Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01334879",
          "briefTitle": "High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05"
          },
          "completionDateStruct": {
            "date": "2012-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Radiation Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04674254",
          "briefTitle": "Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Proliferative Diabetic Retinopathy", "Vascular Endothelial Growth Factor Overexpression", "Diabetic Retinopathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03409250",
          "briefTitle": "SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Choroidal Neovascularization", "Age Related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04047472",
          "briefTitle": "Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 397,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03889444",
          "briefTitle": "Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 141,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03913130",
          "briefTitle": "Extension Study to Study PQ-110-001 (NCT03140969)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leber Congenital Amaurosis 10", "Blindness", "Leber Congenital Amaurosis", "Vision Disorders", "Sensation Disorders", "Neurologic Manifestations", "Eye Diseases", "Eye Diseases, Hereditary", "Eye Disorders Congenital", "Retinal Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00395707",
          "briefTitle": "Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-08"
          },
          "completionDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01982435",
          "briefTitle": "Safety and Efficacy of Ranibizumab for Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-05-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01003106",
          "briefTitle": "Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00921297",
          "briefTitle": "Cataract Removal and Alzheimer's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-06"
          },
          "completionDateStruct": {
            "date": "2017-03-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cataracts", "Alzheimer's Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 122,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02457026",
          "briefTitle": "Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01"
          },
          "completionDateStruct": {
            "date": "2018-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02949024",
          "briefTitle": "Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05608837",
          "briefTitle": "Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Uveitis Related Cystoid Macular Edema", "Cystoid Macular Edema, Postoperative"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03011554",
          "briefTitle": "Telescope Exchange Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06453694",
          "briefTitle": "Efgartigimod for the Treatment of Acute Optic Neuritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Optic Neuritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03552770",
          "briefTitle": "Single or Combined Protocols for NV-AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "95 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01585441",
          "briefTitle": "Finasteride for Chronic Central Serous Chorioretinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04062370",
          "briefTitle": "Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinal Vein Occlusion", "Treatment", "Photocoagulation Burn to Retina", "Ranibizumab"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03677934",
          "briefTitle": "A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 415,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07174726",
          "briefTitle": "A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "X-Linked Retinitis Pigmentosa (XLRP)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "12 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02895815",
          "briefTitle": "Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-08-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Visual Acuity", "Geographic Atrophy", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07133438",
          "briefTitle": "Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Vein Occlusion (RVO)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04985487",
          "briefTitle": "Regulatory Post-Marketing Surveillance Study for Brolucizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00063765",
          "briefTitle": "Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-06"
          },
          "completionDateStruct": {
            "date": "2006-03"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04469595",
          "briefTitle": "A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05331664",
          "briefTitle": "Dropless Pars Plana Vitrectomy Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rhegmatogenous Retinal Detachment"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 168,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02193945",
          "briefTitle": "A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2015-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Symptomatic Vitreomacular Adhesion (VMA)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04085341",
          "briefTitle": "A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Macular Edema", "Retina Vein Occlusion"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05270044",
          "briefTitle": "Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2035-05-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 815,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06985706",
          "briefTitle": "Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Diabetic Macular Oedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02769169",
          "briefTitle": "Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Polypoidal Choroidal Vasculopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01414153",
          "briefTitle": "Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Exudative Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 158,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02510794",
          "briefTitle": "Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-03-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 225,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03500328",
          "briefTitle": "Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis, Relapsing-Remitting"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 900,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02227745",
          "briefTitle": "Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Retinopathy", "Diabetic Macular Edema"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00491166",
          "briefTitle": "Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05834075",
          "briefTitle": "A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neurovascular Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04866719",
          "briefTitle": "PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Spain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cataract", "Lens Opacities", "Astigmatism"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06079593",
          "briefTitle": "GaslEss Macular Hole Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Holes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03063021",
          "briefTitle": "The FIGHT-RP1 Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01648452",
          "briefTitle": "CNTF Implants for CNGB3 Achromatopsia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Eye Disease", "Achromatopsia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04219891",
          "briefTitle": "WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myopia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 272,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01986907",
          "briefTitle": "Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-06-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Age Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1049,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06717048",
          "briefTitle": "Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-06-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myopia", "Refractive Error - Myopia", "Choroidal Thickness", "Retina"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "8 Years",
          "maximumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05996822",
          "briefTitle": "Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Macular Edema"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05413330",
          "briefTitle": "Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabete Type 2", "Cataract", "Triamcinolone Acetonide", "Intravitreal Injection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "49 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02613572",
          "briefTitle": "Alpha Lipoic Acid in Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11"
          },
          "completionDateStruct": {
            "date": "2019-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06294847",
          "briefTitle": "Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinal Detachment"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06952452",
          "briefTitle": "Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 630,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01205035",
          "briefTitle": "High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinal Diseases", "Telangiectasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03203850",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hereditary Hemochromatosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01441102",
          "briefTitle": "Dextromethorphan for Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02591914",
          "briefTitle": "An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2016-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neovascular Age-Related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00470678",
          "briefTitle": "EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {
            "date": "2008-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Choroidal Neovascularization", "Age-Related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 95,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00100087",
          "briefTitle": "Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-10"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Macular Degeneration", "Choroidal Neovascularization"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02464436",
          "briefTitle": "Safety and Tolerability of hRPC in Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03273907",
          "briefTitle": "Post Approval Study of the CyPass System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Open-angle Glaucoma", "Cataract"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 79,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04371523",
          "briefTitle": "Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Corona Virus Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07129239",
          "briefTitle": "High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Wet Age-related Macular Degeneration (wAMD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01941329",
          "briefTitle": "Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "High Risk Proliferative Diabetic Retinopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01376167",
          "briefTitle": "Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria, Vivax"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 851,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01281098",
          "briefTitle": "Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03"
          },
          "completionDateStruct": {
            "date": "2013-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["High Risk Proliferative Diabetic Retinopathy", "Diabetes Mellitus Type I", "Diabetes Mellitus Type II"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06467344",
          "briefTitle": "Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stargardt Disease", "Cone Rod Dystrophy", "Juvenile Macular Degeneration", "Stargardt Disease 1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02317887",
          "briefTitle": "Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-02-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinoschisis", "X-Linked"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04455139",
          "briefTitle": "A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eye Cancer, Retinoblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Months",
          "maximumAge": "11 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02727881",
          "briefTitle": "Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Age-related Macular Degeneration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "110 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00407602",
          "briefTitle": "Argus® II Retinal Stimulation System Feasibility Protocol"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09"
          },
          "completionDateStruct": {
            "date": "2019-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04035369",
          "briefTitle": "Endophthalmitis Post Intravitreal Injections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Endophthalmitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 310,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01468337",
          "briefTitle": "Topical Interferon Gamma-1b for Central Serous Chorioretinopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10"
          },
          "completionDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Retinal Disease", "Macular Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04796545",
          "briefTitle": "Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AMD", "Age-Related Macular Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02511067",
          "briefTitle": "Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ]
  }
}
